Research and Development Grant. Effective as of the Effective Date, BIONUMERIK hereby grants to KI PHARMA and GRELAN an exclusive license under the BioNumerik Patent Rights, Know-How and BioNumerik Improvements to conduct and have conducted research and development of the Venture Products BN in the Territory for the purpose of obtaining Government Regulatory Approvals in the Territory.
Appears in 4 contracts
Samples: Joint Venture Agreement (Bionumerik Pharmaceuticals Inc), Joint Venture Agreement (Bionumerik Pharmaceuticals Inc), Joint Venture Agreement (Bionumerik Pharmaceuticals Inc)
